Co-Diagnostics, Inc. (CODX)

CIK 0001692415 · Healthcare · Medical Devices

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-14) · 99.1
Latest FY-2025 8-K (2026-03-31) · 99.1  |  8-K (2026-03-10)
Q3-2025 8-K (2025-11-13) · 99.1
Q2-2025 8-K (2025-08-14) · 99.1
Q1-2025 8-K (2025-05-08) · 99.1
FY-2024 8-K (2025-03-27) · 99.1
Q3-2024 8-K (2024-11-07) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-09) · 99.1
FY-2023 8-K (2024-03-14) · 99.1
Q3-2023 8-K (2023-11-09) · 99.1
Q2-2023 8-K (2023-08-10) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (unaudited)
—
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statement of Changes In Stockholders' Equity
—
Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Stockholders' Equity (unaudited)
—
Notes
Accrued Expenses
—
At-the-market Agreement
Cash, Cash Equivalents, and Financial Instruments
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Earnings (loss) Per Share
—
Earnings Per Share
—
Fair Value Measurements
Goodwill and Intangible Assets
—
Income Taxes
Insider Trading Arrangements
—
Insider Trading Policies and Procedures
—
Intangible Assets
—
Intangible Assets, Net
—
Investment In Joint Ventures
—
Loss Per Share
Overview and Basis of Presentation
Pay Vs Performance Disclosure
Property and Equipment
—
Registered Direct Offerings
Related Party Transactions
Revenue
Share Repurchase Program
Stock-based Compensation
Subsequent Events
Summary of Significant Accounting Policies